Plasmodium falciparum circumsporozoite protein peptide-MHC-TCR complex (PfCSP pMHC-TCR)

The Plasmodium falciparum circumsporozoite protein (PfCSP) peptide-MHC-TCR complex is a fundamental immunological assembly that mediates the human T-cell response against the pre-erythrocytic stage of malaria. PfCSP is the primary surface antigen of the malaria sporozoite and contains highly conserved and polymorphic T-cell epitopes, such as the Th2R and Th3R regions, which are processed and presented by human Major Histocompatibility Complex (MHC) molecules (HLA Class I and II). Recognition of these peptide-MHC complexes by specific T-cell receptors (TCRs) is essential for activating CD4+ T helper cells and CD8+ cytotoxic T cells, which together work to prevent the parasite from establishing a blood-stage infection. This complex is the central target for leading malaria vaccines, including RTS,S/AS01 and R21/Matrix-M, which aim to elicit high-titer antibodies and robust T-cell memory. However, the significant genetic diversity of PfCSP in field isolates can lead to immune escape, where the vaccine-induced T cells fail to recognize variant peptides presented by MHC molecules. Consequently, characterizing the structural and molecular features of the PfCSP pMHC-TCR interaction is a key focus for developing next-generation vaccines that provide broader and more durable protection against diverse Plasmodium strains.

Other names

PfCSP peptide-MHC-TCR complexCircumsporozoite protein T-cell epitope complexCSP-HLA-TCR complexPlasmodium falciparum CSP-derived peptide-human MHC complex

Induction of protective cellular and humoral immunity by presenting PfCSP-derived epitopes to T cells, which triggers cytokine release (e.g., IFN-gamma), provides B-cell help for antibody production, and activates cytotoxic T cells to eliminate infected hepatocytes.